Deep Brain Stimulation in Parkinson’s Disease Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Deep Brain Stimulation in Parkinson’s Disease Market size was estimated at USD 712.67 million in 2020 and expected to reach USD 815.87 million in 2021, at a CAGR 14% to reach USD 1,885.68 million by 2028.

Deep brain stimulation is defined as surgery in which electrical devices are implanted in the body. This device is responsible for sending electrical signals to the areas of the brain responsible for body movement. Also, a device used to monitor stimulation of the brain is called a deep brain stimulation device. This device is used in the treatment of various neurological disorders such as Parkinson’s disease, epilepsy, essential tremor, dystonia, obsessive compulsive disorder, etc. Deep brain stimulation devices are also used to block pain signals by sending electrical impulses near the spine.

Market Segments

By Product

• Single Channel Deep Brain Stimulator
• Dual Channel Deep Brain Stimulator

By End-user

• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers (ASCs)
• Research Centers

Key Players

Global Deep Brain Stimulation in Parkinson’s Disease Market, including Abbott Laboratories, Aleva Neurotherapeutics SA, Allergan Plc, Beijing PINS Medical Co. Ltd, Boston Scientific Corporation, Cyberonics, Inc, Fisher Wallace, Functional Neuromodulation Ltd, LIVANOVA PLC, Medtronic PLC, MicroTransponder Inc, Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nevro Corporation, Nexstim Oy, Renishaw PLC, ReShape Lifesciences, Inc, Synapse Biomedical Inc, and Zynex, Inc.

Scope of the Report

The research study analyzes the global Deep Brain Stimulation in Parkinson’s Disease industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Deep Brain Stimulation in Parkinson’s Disease Market Report

1. What was the Deep Brain Stimulation in Parkinson’s Disease Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Deep Brain Stimulation in Parkinson’s Disease Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Deep Brain Stimulation in Parkinson’s Disease Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.